To test the hypothesis that haemoglobin concentration is a poor predictor of benefit from transfusion in preterm infants, and that red cell volume is the most important indicator of anaemia, 24 preterm infants receiving red cell transfusions had red cell volume, haemoglobin concentration, and cardiac output measured before and after transfusion. Red cell volume was measured either using dilution of autologous fetal haemoglobin with donor adult haemoglobin, or with a new technique using biotin as a red cell label. The two techniques give similar results. Mean (SD) values before transfusion were 27-4 (13.3), and after transfusion 45 0 (13.7) mI/kg. Cardiac output was measured using imaging and Doppler ultrasonography, and fell with transfusion from mean 286 (121) to 251 (95.6) ml/kg/min. The red cell volume before transfusion correlated well with changes in cardiac output following transfusion, infants with a red cell volume before transfusion of less than 25 ml/kg showing a fall in cardiac output, and those with a red cell volume of greater than 25 ml/kg not showing a significant fall. There was no correlation between haemoglobin concentration, packed cell volume, or change in packed cell volume with changes in cardiac output after transfusion.
Blood transfusions are commonly used in the management of preterm infants yet indications for transfusion and volumes of blood used vary widely. Haemoglobin concentration before transfusion is a poor predictor of benefit from red cell transfusion,' 2 and it has been suggested tht the red cell volume (synonymous with red cell mass) is theoretically a better guide to transfusion needs.5 The relationship between red cell volume and haemoglobin concentration varies"; though some of this variation may be explained by differences in sampling sites for haemoglobin concentration, it may also be the result of differences in plasma volume among infants. Some infants have low red cell volumes, yet maintain a relatively normal haemoglobin concentration.4'6 The association of decreasing blood volume and a decreasing red cell volume may partly explain this phenomenon.3 '6 In anaemic infants the packed cell volume is low. This reduces the oxygen carrying capacity of the blood but is partly compensated for by reduced viscosity of the blood and consequent reduced resistance to blood flow; flow increases thus partly restoring oxygen delivery. It has been calculated that the optimal packed cell volume for oxygen transport is about 40%.8 The effective reduction in peripheral vascular resistance should result in an increase in venous return and so in cardiac output.
An increased cardiac output has been found in anaemic adults9 as well as in newborn infants,'0 and theoretically should also occur in anaemic infants.3
The purpose of this study was to investigate the value of measurements of red cell volume in predicting the need for, and benefit from, red cell transfusion defined by a fall in cardiac output.
Patients and methods Cardiac output, red cell volume, haemoglobin concentration and packed cell volume were measured before and after red cell transfusions in 24 preterm infants without clinical evidence of patent ductus arteriosus. The decision to transfuse was made on clinical grounds independently of this study. Details of the infants are given in table 1.
Ten infants were ventilated, four were being given supplementary oxygen, and 10 were breathing air at the time of study. Measurements were made while the infants were either asleep or in a quiet but alert state, and being nursed in an incubator or cot, as clinically indicated. As far as possible subsequent measurements were made with the infants in a similai state on each occasion. CALCULATION It was assumed that the aortic diameter measured at the annulus did not change appreciably in the 24 hours after transfusion, and this measurement was used on both occasions. The percentage change in cardiac output within an infant is therefore independent of the aortic diameter, thus enabling more accurate comparison among different infants.
Measurements were made before the blood transfusion and were repeated 12-24 hours afterwards.
MEASUREMENT OF RED CELL VOLUME Red cell volume was measured by either diluting the fetal haemoglobin with donor adult haemoglobin4 or labelling the red cells with a biotin tracer. 6 The former method could only be used if at least 20% fetal haemoglobin was present before the transfusion. This was possible in 20 infants. The concentration of fetal haemoglobin was accurately measured using an alkali denaturation technique. The biotin method for measuring red cell volume was used in four infants with low concentrations of fetal haemoglobin and also in six others at the same time as the dilution of fetal haemoglobin with donor adult haemoglobin as part of a previous study to confirm that the two methods gave similar results (table 2) .
The technique for measuring red cell volume in preterm infants using biotin labelling of red cells has been described in detail previously.6 Autologous red cells were labelled with long chain water soluble biotin (NHS-LC-biotin sulfosuccinimidyl 6-(biotinamide))(Hexanoate, Pierce Chemical Company) and reinjected. Blood samples were then taken from the infant at 10 and 30 minutes and combined with fluorescein-streptavidin (Amersham International), which allowed the proportion of positively labelled cells to be detected on a fluorescence activated cell sorter.
Haemoglobin The relationship between the red cell volume and haemoglobin concentration before transfusion is shown in fig 1 (r=0-663) .
Cardiac 
fusion (Student's t test for paired samples, p<O0OS).
Four of the 24 infants had patent ductus arteriosus shown on Doppler ultrasonography. Figure 2 shows the relationship between the percentage change in cardiac output and the red cell volume before transfusion for infants without patent ductus arteriosus. This relationship is expressed by the equation: percentage change in cardiac output= 153-944x red cell volume+ 0-143 (red cell volume).2 The appropriate SE of the coefficients are 36, 2-9, and 0-054, and the t ratios 4-26, -3-22, and 2-64. R-sq=65-0%. The estimated standard deviation of the percentage change is 14-04. Clearly all terms in the relationship are significantly different from zero. It shows that those infants with a red cell volume of more than 25 ml/kg before transfusion did not have a significant fall in cardiac output, whereas those infants who had a red cell volume of less than 25 ml/kg before transfusion did have a significant fall in cardiac output. There was no significant relationship between the percentage change in cardiac output and haemoglobin concentration before transfusion (fig 3) , (R-sq=15-5%). Similarly there was no significant relationship between percentage change in cardiac output and packed cell volume before transfusion (R-sq 15-1%), change in packed cell volume (R-sq 6-6%), or change in haemoglobin concentration (r-sq 4.1%).
Discussion
The ability to predict benefit from blood transfusion reliably would permit better prescribing of red cell transfusion, and would lead to a reduction in exposure to donors and hence the risks of transfusion transmitted infection. This study confirms the variable relationship between red cell volume and haemoglobin concentration, and this may partly explain why the haemoglobin concentration is a poor predictor of benefit from blood transfusion. Measurements of cardiac output and red cell volume were made before and after blood transfusion. In the analysis of the results, infants in whom patent ductus arteriosus was found either before, after, or both before and after (n=4), were excluded. Alverson et al found that infants with patent ductus arteriosus had increased cardiac output,'2 and it is not yet fully established what the effect of transfusion is on shunt size in these infants.
The mean cardiac output was significantly lowered after transfusion; others, however, have not found this change to be significant.' In the present study larger volumes of red cells were used (about 20 ml/kg) than in other studies, 10 found in this study may be the result of several factors. Firstly, the sampled packed cell volume may bear only a limited association to total body packed cell volume (red cell volume/total blood volume). Correction factors have been derived to correct for total body to venous packed cell volume ratios, but these are mean values for a number of newborn infants and considerable individual variation might be expected.'3 14 The relationship between total body and venous packed cell volume ratios have not been fully investigated in sick newborn infants, and the individual variation may be even greater. Secondly, total blood volume, which appears to be related to red cell volume,3 6 may play an important part. There seems to be no evidence that plasma volume expands in anaemic infants,3 and therefore in these infants with reduced red cell volume the effect of a reduction in blood volume and shunting to maintain flow to vital organs is superimposed on the effects of a reduced packed cell volume. Bifano et al found that albumin infusions given to anaemic infants relieved the apnoea that had been attributed to the anaemia, at least during the 24 hours after the infusion.'5 It seems likely, therefore, that some of the symptoms attributed to the anaemia of prematurity are the result of the reductions in blood volume found in anaemic infants.
This study clearly shows that changes in cardiac output associated with transfusion were significantly related to red cell volume but not to haemoglobin concentration or packed cell volume. Red cell volume may therefore be a better guide for decisions on when to transfuse and a better predictor ofbenefit from tranfusion. I H was supported by a grant from Scottish Hospitals Endowment Research Trust. We thank the staff of the medical illustration department, Royal Hospital for Sick Children, Glasgow, for their help with the illustrations and Mr T Aitchison for advice and help with the statistical analysis.
